Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs</p>
Jens Hagenow, Stefanie Hagenow, Kathrin Grau, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 371-393
Open Access | Times Cited: 23

Showing 23 citing articles:

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 71
Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors
Sunil Kumar, Ratul Bhowmik, Jong‐Min Oh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations
Jisna Jose, Jibin K. Varughese, Mohammad K. Parvez, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 6
Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity
Fatih Tok, Begüm Nurpelin Sağlık, Yusuf Özkay, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105038-105038
Closed Access | Times Cited: 39
Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer
Sanaa K. Bardaweel, Reem Aljanabi, Dima A. Sabbah, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2887-2887
Open Access | Times Cited: 19
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
Plants from the Annonaceous family acting on the Central Nervous System: A comprehensive review to identify potential species
R.L.S.A. Luz, Alexsandro Branco, Mariana Borges Botura
South African Journal of Botany (2025) Vol. 180, pp. 870-893
Closed Access
Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases
M. S. Vishnu, V. Pavankumar, Sandeep Kumar, et al.
ChemMedChem (2019) Vol. 14, Iss. 14, pp. 1359-1376
Closed Access | Times Cited: 22
Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors
Derya Osmani̇ye, Berkant Kurban, Begüm Nurpelin Sağlık, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6640-6640
Open Access | Times Cited: 16
Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed
Firoz Anwar, Salma Naqvi, Fahad A. Al‐Abbasi, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 12, pp. 2392-2408
Closed Access | Times Cited: 17
Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
Muhammed Çeçen, Jong‐Min Oh, Zeynep Özdemir, et al.
Molecules (2020) Vol. 25, Iss. 22, pp. 5371-5371
Open Access | Times Cited: 15
Ginkgo biloba: Antioxidant Activity and In Silico Central Nervous System Potential
Eduardo Suárez-González, Jesús Sandoval-Ramı́rez, Jorge Flores‐Hernández, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9674-9691
Open Access | Times Cited: 5
Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions
Bijo Mathew, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1148-1148
Open Access | Times Cited: 12
Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
Aathira Sujathan Nair, Jong‐Min Oh, Vishal Payyalot Koyiparambath, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3264-3264
Open Access | Times Cited: 11
In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases
Purusottam Banjare, Balaji Wamanrao Matore, Anjali Murmu, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 29, pp. 2765-2791
Closed Access | Times Cited: 4
AI molecular property prediction for Parkinson's Disease reveals potential repurposing drug candidates based on the increase of the expression of PINK1
Jacek Haneczok, Marcin Delijewski, Rudolf Moldzio
Computer Methods and Programs in Biomedicine (2023) Vol. 241, pp. 107731-107731
Closed Access | Times Cited: 3
(Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors
Ashique Palakkathondi, Jong‐Min Oh, Sanal Dev, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 11, pp. 592-599
Closed Access | Times Cited: 6
An in Silico Study of Natural Compounds as Potential MAO-B Inhibitors for the Treatment of Parkinson’s Disease
Bianca L. B. Marino, Kessia P.A. Sousa, Cleydson B. R. Santos, et al.
Engineering materials (2021), pp. 591-617
Closed Access | Times Cited: 4
Benzocaine as a precursor of promising derivatives: synthesis, reactions, and biological activity
Israa Taha, Eman M. Keshk, Abdel‐Galil M. Khalil, et al.
Chemical Papers (2021) Vol. 75, Iss. 12, pp. 6181-6215
Closed Access | Times Cited: 4
Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications
Anjali Murmu, Balaji Wamanrao Matore, Purusottam Banjare, et al.
(2023), pp. 245-284
Closed Access | Times Cited: 1
Synthesis and pharmacological evaluation of selective MAO-A inhibitors using structure and pharmacophore-based drug design
Mule Vijayalakshmi, A. Suresh, S. Vadivelan, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137302-137302
Closed Access | Times Cited: 1
Quantitative Structure–Neurotoxicity Assessment and In Vitro Evaluation of Neuroprotective and MAO-B Inhibitory Activities of Series N′-substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazides
Magdalena Kondeva-Burdina, Javor Mitkov, Iva Valkova, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5321-5321
Open Access | Times Cited: 1
In Silico Drug Design and in Vivo Acute Toxicity Assay of Chalcone Analogs with Biological Antiparkinsonian Activity
Bianca L. B. Marino, Jaderson V. Ferreira, L. Brenda Sánchez-Ortiz, et al.
Engineering materials (2022), pp. 361-387
Closed Access
Page 1

Scroll to top